Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 8/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 5/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3895683 | 0.89 | NAAA (0.35) | ACHEHRH4HRH3ALDH1A1NAAA | |
| SCHEMBL1884857 | 0.79 | ALDH1A1 (0.40) | ACHEHRH4HRH3ALDH1A1 | |
| SCHEMBL3883106 | 0.78 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL3884167 | 0.78 | NAAA (0.36) | NAAA | |
| SCHEMBL1884821 | 0.76 | ACHE (0.42) | ACHEHRH4HRH3ALDH1A1NAAA | |
| SCHEMBL3883733 | 0.76 | ADRB2 (0.41) | ALDH1A1 | |
| SCHEMBL3891100 | 0.76 | ADRB2 (0.41) | ALDH1A1 | |
| SCHEMBL6066161 | 0.76 | ACHE (0.42) | ACHEHRH4HRH3ALDH1A1NAAA | |
| SCHEMBL1883560 | 0.76 | ALDH1A1 (0.37) | ACHEHRH4HRH3ALDH1A1 | |
| SCHEMBL3883788 | 0.75 | ADRB2 (0.38) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7566738-B2 | Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use | XENOPORT, INC. (US) | 2009-07-28 | — | — | US | disclosed |
| US-20080242723-A1 | ACYLOXYALKYL CARBAMATE PRODRUGS OF SULFINIC ACIDS, METHODS OF SYNTHESIS, AND USE | XENOPORT, INC. (US) | 2008-10-02 | — | — | US | disclosed |
| US-20060111439-A1 | Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use | XENOPORT, INC. | 2006-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242723-A1 | ACYLOXYALKYL CARBAMATE PRODRUGS OF SULFINIC ACIDS, METHODS OF SYNTHESIS, AND USE | ASS1, APEH, ACMSD | ACHE 450/4885HRH4 220/4885HRH3 550/4885 |
| US-20060111439-A1 | Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use | ASS1, APEH, ACMSD | ACHE 450/4885HRH4 220/4885HRH3 550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.